Application 219773
- Type
- ANDA
- Sponsor
- MANKIND PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EXTENDED PHENYTOIN SODIUM | PHENYTOIN SODIUM | CAPSULE;ORAL | 100MG EXTENDED | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219773-001 | EXTENDED PHENYTOIN SODIUM | PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | 2026-01-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219773-001 | EXTENDED PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | 2026-01-02 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A219773-001 | EXTENDED PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | 2026-01-02 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A219773-001 | EXTENDED PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | AB | 2026-01-02 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219773-001 | EXTENDED PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | AB | 2026-01-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219773-001 | AB | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219773-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenytek | EXTENDED PHENYTOIN SODIUM | Mylan Pharmaceuticals Inc. | 0f94c791-8b07-4b41-927e-c9f28bec5f60 | 2024-10-15 | Warnings, Adverse reactions | PHENYTOIN SODIUM |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | Acella Pharmaceuticals, LLC | 6922f32f-8bed-4c09-8103-27987bcbd104 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Phenytoin Sodium | PHENYTOIN SODIUM | A-S Medication Solutions | d4459837-da26-4c97-8587-32eb1f682d58 | 2024-05-22 | Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Phenytoin Sodium | PHENYTOIN SODIUM | Hikma Pharmaceuticals USA Inc. | 035a8d4e-2063-4240-83cb-d7eebcabe301 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Phenytoin Sodium | PHENYTOIN SODIUM | Hikma Pharmaceuticals USA Inc. | 8ad1be7b-a1a4-4a2a-bf9b-d22b350aa6e7 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 7607ddff-2f1c-272c-e053-2991aa0a1ab3 | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Phenytoin Sodium | PHENYTOIN SODIUM | Medical Purchasing Solutions, LLC | 0aac9dcd-c4df-84d9-e063-6294a90a0376 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Extended Phenytoin Sodium | PHENYTOIN SODIUM | Aurobindo Pharma Limited | 5362ea50-38a4-48b4-a85b-d634c3d8b91a | 2023-09-21 | Warnings, Adverse reactions | Extended Phenytoin Sodium PHENYTOIN SODIUM |
| phenytoin sodium | PHENYTOIN SODIUM | Sun Pharmaceutical Industries, Inc. | c40f66cc-6f4a-4b29-84ba-d265e4848735 | 2022-12-14 | Warnings, Adverse reactions | PHENYTOIN SODIUM |
| PHENYTOIN SODIUM | PHENYTOIN SODIUM | HF Acquisition Co LLC, DBA HealthFirst | 763b549d-9b78-09dd-e053-2a91aa0aec7f | 2022-12-09 | Boxed warning, Warnings, Adverse reactions | PHENYTOIN SODIUM |
| Phenytoin Sodium | PHENYTOIN SODIUM | Unichem Pharmaceuticals (USA), Inc. | afdf66e0-5f99-444e-bc06-2fdddc507f5c | 2022-10-19 | Warnings, Adverse reactions | PHENYTOIN SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.